Global Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

October 2022 | 175 pages | ID: G520E4CFED39EN
GMD Research

Abstracts

Global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.

Highlighted with 92 tables and 79 figures, this 175-page report “Global Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Region.

Based on Component, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Consumables
• Software
• Services

Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE?Saudi Arabia? South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

10x Genomics

Agilent Technologies, Inc.

ANGLE plc

Becton, Dickinson and Company (BD)

Bio-Rad Laboratories, Inc.

BioSypder, Inc.

Bio-Techne

Cytiva

F. Hoffmann-La Roche Ltd.

Fluidigm Corporation

GE Healthcare

Illumina, Inc.

Menarini Silicon Biosystems

Merck & Co., Inc.

NanoString

Pacific Biosciences of California, Inc.

PerkinElmer Inc.

Promega Corporation

Qiagen N. V.

Takara Bio Inc.

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY COMPONENT

3.1 Market Overview by Component
3.2 Instruments
3.3 Consumables
3.4 Software
3.5 Services

4 SEGMENTATION OF GLOBAL MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Polymerase Chain Reaction (PCR)
4.3 Next-Generation Sequencing
4.4 Microarray
4.5 In-Situ Hybridization (ISH)
4.6 Gene Regulation Technologies
4.7 Other Technologies

5 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Drug Discovery and Development
5.3 Diagnostics
5.4 Single Cell Analysis
5.5 Gene Expression
5.6 Cell Biology
5.7 Other Applications

6 SEGMENTATION OF GLOBAL MARKET BY END USER

6.1 Market Overview by End User
6.2 Academic and Research Institutions
6.3 Biotechnology and Biopharmaceutical Companies
6.4 Contract Research Organizations (CROs)
6.5 Other End Users

7 SEGMENTATION OF GLOBAL MARKET BY REGION

7.1 Geographic Market Overview 2021-2031
7.2 North America Market 2021-2031 by Country
  7.2.1 Overview of North America Market
  7.2.2 U.S.
  7.2.3 Canada
  7.2.4 Mexico
7.3 European Market 2021-2031 by Country
  7.3.1 Overview of European Market
  7.3.2 Germany
  7.3.3 U.K.
  7.3.4 France
  7.3.5 Spain
  7.3.6 Italy
  7.3.7 Netherlands
  7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2021-2031 by Country
  7.4.1 Overview of Asia-Pacific Market
  7.4.2 Japan
  7.4.3 China
  7.4.4 Australia
  7.4.5 India
  7.4.6 South Korea
  7.4.7 Rest of APAC Region
7.5 South America Market 2021-2031 by Country
  7.5.1 Argentina
  7.5.2 Brazil
  7.5.3 Chile
  7.5.4 Rest of South America Market
7.6 MEA Market 2021-2031 by Country
  7.6.1 UAE
  7.6.2 Saudi Arabia
  7.6.3 South Africa
  7.6.4 Other National Markets

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles

10X GENOMICS

Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Transcriptomics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Transcriptome Databases
Table 4. World Personalized Medicine Market, 2021-2031, $ bn
Table 5. Main Product Trends and Market Opportunities in Global Transcriptomics Market
Table 6. Global Transcriptomics Market by Component, 2021-2031, $ mn
Table 7. Main Instrument Products from Key Vendors
Table 8. Main Consumable Products from Key Vendors
Table 9. Main Software Products from Key Vendors
Table 10. Global Transcriptomics Market by Technology, 2021-2031, $ mn
Table 11. Main PCR-based Transcriptomics and Key Vendors
Table 12. Main NGS-based Transcriptomics and Key Vendors
Table 13. Main Microarray-based Transcriptomics and Key Vendors
Table 14. Main ISH-based Transcriptomics and Key Vendors
Table 15. Global Transcriptomics Market by Application, 2021-2031, $ mn
Table 16. Global Transcriptomics Market by End User, 2021-2031, $ mn
Table 17. Global Transcriptomics Market by Region, 2021-2031, $ mn
Table 18. Leading National Transcriptomics Market, 2021 and 2031, $ mn
Table 19. North America Transcriptomics Market by Country, 2021-2031, $ mn
Table 20. U.S. Transcriptomics Market by Component, 2021-2031, $ mn
Table 21. U.S. Transcriptomics Market by Technology, 2021-2031, $ mn
Table 22. U.S. Transcriptomics Market by Application, 2021-2031, $ mn
Table 23. Canada Transcriptomics Market by Component, 2021-2031, $ mn
Table 24. Canada Transcriptomics Market by Technology, 2021-2031, $ mn
Table 25. Canada Transcriptomics Market by Application, 2021-2031, $ mn
Table 26. Mexico Transcriptomics Market by Component, 2021-2031, $ mn
Table 27. Mexico Transcriptomics Market by Technology, 2021-2031, $ mn
Table 28. Mexico Transcriptomics Market by Application, 2021-2031, $ mn
Table 29. Europe Transcriptomics Market by Country, 2021-2031, $ mn
Table 30. Germany Transcriptomics Market by Component, 2021-2031, $ mn
Table 31. Germany Transcriptomics Market by Technology, 2021-2031, $ mn
Table 32. Germany Transcriptomics Market by Application, 2021-2031, $ mn
Table 33. U.K. Transcriptomics Market by Component, 2021-2031, $ mn
Table 34. U.K. Transcriptomics Market by Technology, 2021-2031, $ mn
Table 35. U.K. Transcriptomics Market by Application, 2021-2031, $ mn
Table 36. France Transcriptomics Market by Component, 2021-2031, $ mn
Table 37. France Transcriptomics Market by Technology, 2021-2031, $ mn
Table 38. France Transcriptomics Market by Application, 2021-2031, $ mn
Table 39. Spain Transcriptomics Market by Component, 2021-2031, $ mn
Table 40. Spain Transcriptomics Market by Technology, 2021-2031, $ mn
Table 41. Spain Transcriptomics Market by Application, 2021-2031, $ mn
Table 42. Italy Transcriptomics Market by Component, 2021-2031, $ mn
Table 43. Italy Transcriptomics Market by Technology, 2021-2031, $ mn
Table 44. Italy Transcriptomics Market by Application, 2021-2031, $ mn
Table 45. Netherlands Transcriptomics Market by Component, 2021-2031, $ mn
Table 46. Netherlands Transcriptomics Market by Technology, 2021-2031, $ mn
Table 47. Netherlands Transcriptomics Market by Application, 2021-2031, $ mn
Table 48. Transcriptomics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 49. APAC Transcriptomics Market by Country, 2021-2031, $ mn
Table 50. Japan Transcriptomics Market by Component, 2021-2031, $ mn
Table 51. Japan Transcriptomics Market by Technology, 2021-2031, $ mn
Table 52. Japan Transcriptomics Market by Application, 2021-2031, $ mn
Table 53. China Transcriptomics Market by Component, 2021-2031, $ mn
Table 54. China Transcriptomics Market by Technology, 2021-2031, $ mn
Table 55. China Transcriptomics Market by Application, 2021-2031, $ mn
Table 56. Australia Transcriptomics Market by Component, 2021-2031, $ mn
Table 57. Australia Transcriptomics Market by Technology, 2021-2031, $ mn
Table 58. Australia Transcriptomics Market by Application, 2021-2031, $ mn
Table 59. India Transcriptomics Market by Component, 2021-2031, $ mn
Table 60. India Transcriptomics Market by Technology, 2021-2031, $ mn
Table 61. India Transcriptomics Market by Application, 2021-2031, $ mn
Table 62. South Korea Transcriptomics Market by Component, 2021-2031, $ mn
Table 63. South Korea Transcriptomics Market by Technology, 2021-2031, $ mn
Table 64. South Korea Transcriptomics Market by Application, 2021-2031, $ mn
Table 65. Transcriptomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 66. South America Transcriptomics Market by Country, 2021-2031, $ mn
Table 67. Argentina Transcriptomics Market by Component, 2021-2031, $ mn
Table 68. Argentina Transcriptomics Market by Technology, 2021-2031, $ mn
Table 69. Argentina Transcriptomics Market by Application, 2021-2031, $ mn
Table 70. Brazil Transcriptomics Market by Component, 2021-2031, $ mn
Table 71. Brazil Transcriptomics Market by Technology, 2021-2031, $ mn
Table 72. Brazil Transcriptomics Market by Application, 2021-2031, $ mn
Table 73. Chile Transcriptomics Market by Component, 2021-2031, $ mn
Table 74. Chile Transcriptomics Market by Technology, 2021-2031, $ mn
Table 75. Chile Transcriptomics Market by Application, 2021-2031, $ mn
Table 76. MEA Transcriptomics Market by Country, 2021-2031, $ mn
Table 77. UAE Transcriptomics Market by Component, 2021-2031, $ mn
Table 78. UAE Transcriptomics Market by Technology, 2021-2031, $ mn
Table 79. UAE Transcriptomics Market by Application, 2021-2031, $ mn
Table 80. Saudi Arabia Transcriptomics Market by Component, 2021-2031, $ mn
Table 81. Saudi Arabia Transcriptomics Market by Technology, 2021-2031, $ mn
Table 82. Saudi Arabia Transcriptomics Market by Application, 2021-2031, $ mn
Table 83. South Africa Transcriptomics Market by Component, 2021-2031, $ mn
Table 84. South Africa Transcriptomics Market by Technology, 2021-2031, $ mn
Table 85. South Africa Transcriptomics Market by Application, 2021-2031, $ mn
Table 86. Breakdown of World Market by Key Vendor, 2021, %
Table 87. Transcriptomic Products Approved by FDA
Table 88. Sequencing Technology Platforms for RNA-Sequencing
Table 89. RNA-Sequencing De Novo Assembly Software
Table 90. 10x Genomics: Company Snapshot
Table 91. 10x Genomics: Business Segmentation
Table 92. 10x Genomics: Product Portfolio

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Transcriptomics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Transcriptomics Market
Figure 7. Primary Restraints and Impact Factors of Global Transcriptomics Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Global Transcriptomics Market
Figure 10. Breakdown of Global Transcriptomics Market by Component, 2021-2031, % of Revenue
Figure 11. Global Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)
Figure 12. Global Transcriptomics Market by Component: Instruments, 2021-2031, $ mn
Figure 13. Global Transcriptomics Market by Component: Consumables, 2021-2031, $ mn
Figure 14. Global Transcriptomics Market by Component: Software, 2021-2031, $ mn
Figure 15. Global Transcriptomics Market by Component: Services, 2021-2031, $ mn
Figure 16. Breakdown of Global Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue
Figure 17. Global Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 18. Global Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn
Figure 19. Global Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn
Figure 20. Global Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn
Figure 21. Global Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn
Figure 22. Global Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn
Figure 23. Global Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 24. Breakdown of Global Transcriptomics Market by Application, 2021-2031, % of Sales Revenue
Figure 25. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 26. Global Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn
Figure 27. Global Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn
Figure 28. Global Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn
Figure 29. Global Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn
Figure 30. Global Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn
Figure 31. Global Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn
Figure 32. Breakdown of Global Transcriptomics Market by End User, 2021-2031, % of Revenue
Figure 33. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 34. Global Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn
Figure 35. Global Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn
Figure 36. Global Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn
Figure 37. Global Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn
Figure 38. Global Market Snapshot by Region
Figure 39. Geographic Spread of Worldwide Transcriptomics Market, 2021-2031, % of Sales Revenue
Figure 40. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 41. North American Transcriptomics Market, 2021-2031, $ mn
Figure 42. Breakdown of North America Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 43. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 44. U.S. Transcriptomics Market, 2021-2031, $ mn
Figure 45. Canada Transcriptomics Market, 2021-2031, $ mn
Figure 46. Transcriptomics Market in Mexico, 2021-2031, $ mn
Figure 47. European Transcriptomics Market, 2021-2031, $ mn
Figure 48. Breakdown of European Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 49. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 50. Transcriptomics Market in Germany, 2021-2031, $ mn
Figure 51. Transcriptomics Market in U.K., 2021-2031, $ mn
Figure 52. Transcriptomics Market in France, 2021-2031, $ mn
Figure 53. Transcriptomics Market in Spain, 2021-2031, $ mn
Figure 54. Transcriptomics Market in Italy, 2021-2031, $ mn
Figure 55. Transcriptomics Market in Netherlands, 2021-2031, $ mn
Figure 56. Transcriptomics Market in Rest of Europe, 2021-2031, $ mn
Figure 57. Asia-Pacific Transcriptomics Market, 2021-2031, $ mn
Figure 58. Breakdown of APAC Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 59. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 60. Transcriptomics Market in Japan, 2021-2031, $ mn
Figure 61. Transcriptomics Market in China, 2021-2031, $ mn
Figure 62. Transcriptomics Market in Australia, 2021-2031, $ mn
Figure 63. Transcriptomics Market in India, 2021-2031, $ mn
Figure 64. Transcriptomics Market in South Korea, 2021-2031, $ mn
Figure 65. Transcriptomics Market in Rest of APAC, 2021-2031, $ mn
Figure 66. South America Transcriptomics Market, 2021-2031, $ mn
Figure 67. Breakdown of South America Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 68. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 69. Transcriptomics Market in Argentina, 2021-2031, $ mn
Figure 70. Transcriptomics Market in Brazil, 2021-2031, $ mn
Figure 71. Transcriptomics Market in Chile, 2021-2031, $ mn
Figure 72. Transcriptomics Market in Rest of South America, 2021-2031, $ mn
Figure 73. Transcriptomics Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 74. Breakdown of MEA Transcriptomics Market by Country, 2021 and 2031, % of Revenue
Figure 75. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 76. Transcriptomics Market in UAE, 2021-2031, $ mn
Figure 77. Transcriptomics Market in Saudi Arabia, 2021-2031, $ mn
Figure 78. Transcriptomics Market in South Africa, 2021-2031, $ mn
Figure 79. Growth Stage of Global Transcriptomics Industry over the Forecast Period